Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Nautical9 / Flickr Creative Commons
The genetic testing company 23andMe has a new study on the genetic links to pain tolerance, which involves two surveys on pain tolerance and history, and an at-home experiment, per MIT's Technology Review.
The experiment: In addition to answering questions about their pain tolerance and history, participants are asked to perform a cold pressor test (a common pain tolerance test), which involves keeping their hands in ice water for up to 3 minutes. Instead of meeting in a lab for the experiment, participants will test themselves from home — the company's first attempt at in-home research and one they hope will gather data from 20,000 participants.
The goal: To "understand genetic factors associated with experiencing pain and response to medications that help alleviate pain," Carrie Northover, 23andMe's director of research services, told Tech Review. The company hopes to find ways of personalizing pain management and medication according to how people process pain.